• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.

作者信息

Maltais François, Mahler Donald A, Pepin Véronique, Nadreau Eric, Crater Glenn D, Morris Andrea N, Emmett Amanda H, Ferro Thomas J

出版信息

Eur Respir J. 2013 Aug;42(2):539-41. doi: 10.1183/09031936.00074113.

DOI:10.1183/09031936.00074113
PMID:23904549
Abstract
摘要

相似文献

1
Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.丙酸氟替卡松/沙美特罗加噻托溴铵与噻托溴铵对慢性阻塞性肺疾病患者步行耐力的影响
Eur Respir J. 2013 Aug;42(2):539-41. doi: 10.1183/09031936.00074113.
2
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.沙美特罗/丙酸氟替卡松或噻托溴铵预防慢性阻塞性肺疾病急性加重
Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. doi: 10.1164/rccm.200707-973OC. Epub 2007 Oct 4.
3
Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.噻托溴铵联合福莫特罗与沙美特罗联合氟替卡松治疗中度慢性阻塞性肺疾病的比较
Chest. 2008 Aug;134(2):255-262. doi: 10.1378/chest.07-2138. Epub 2008 Apr 10.
4
[Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].沙美特罗与噻托溴铵联合使用对慢性阻塞性肺疾病患者的支气管扩张疗效
Arch Bronconeumol. 2005 Mar;41(3):130-4. doi: 10.1016/s1579-2129(06)60413-8.
5
Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.噻托溴铵联合丙酸氟替卡松/沙美特罗与噻托溴铵治疗 COPD 的随机对照研究。
Respir Med. 2012 Mar;106(3):382-9. doi: 10.1016/j.rmed.2011.09.004. Epub 2011 Oct 4.
6
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.沙美特罗与丙酸氟替卡松在慢性阻塞性肺疾病中起效的早期表现
Thorax. 2005 Apr;60(4):301-4. doi: 10.1136/thx.2004.025411.
7
Effect of combination treatment on lung volumes and exercise endurance time in COPD.联合治疗对 COPD 患者肺容积和运动耐力时间的影响。
Respir Med. 2012 Oct;106(10):1413-20. doi: 10.1016/j.rmed.2012.05.011. Epub 2012 Jun 28.
8
Withdrawal of inhaled glucocorticoids and exacerbations of COPD.吸入性糖皮质激素的撤药与 COPD 恶化。
N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8.
9
Stepping down therapy in COPD.慢性阻塞性肺疾病的降阶梯治疗
N Engl J Med. 2014 Oct 2;371(14):1340-1. doi: 10.1056/NEJMe1409219. Epub 2014 Sep 8.
10
An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses.使用噻托溴铵或沙美特罗进行的急性支气管扩张试验无法根据反应对患者进行细分。
Respiration. 2005 Sep-Oct;72(5):466-70. doi: 10.1159/000087669.

引用本文的文献

1
Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus.用于 COPD 患者三联疗法的临床概念：德尔菲共识。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 28;18:1853-1866. doi: 10.2147/COPD.S424128. eCollection 2023.
2
Automated O Titration Alone or With High-Flow Nasal Cannula During Walking Exercise in Chronic Lung Diseases.慢性肺部疾病患者步行锻炼期间单独使用自动氧滴定法或联合高流量鼻导管吸氧
Respir Care. 2023 Dec 28;69(1):1-14. doi: 10.4187/respcare.10810.
3
Triple therapy for COPD: a crude analysis from a systematic review of the evidence.
COPD 的三联疗法：对证据的系统评价的粗糙分析。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619885522. doi: 10.1177/1753466619885522.
4
The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.单吸入器三联疗法与单吸入器双联疗法或单独三联疗法治疗慢性阻塞性肺疾病的效果：系统评价和随机对照试验的荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 11;14:1539-1548. doi: 10.2147/COPD.S200846. eCollection 2019.
5
Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.三联疗法治疗慢性阻塞性肺疾病的系统评价和荟萃分析。
BMJ. 2018 Nov 6;363:k4388. doi: 10.1136/bmj.k4388.
6
Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.对于慢性阻塞性肺疾病患者，每日一次长效β₂受体激动剂/吸入性糖皮质激素联合吸入器与吸入性长效毒蕈碱拮抗剂的比较
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012355. doi: 10.1002/14651858.CD012355.pub2.
7
Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.在慢性阻塞性肺疾病患者中，每日一次噻托溴铵/奥达特罗治疗 12 周对恒功率踏车运动和耐力往返步行运动耐力的影响。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465818755091. doi: 10.1177/1753465818755091.
8
Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.吸入性糖皮质激素与长效β₂受体激动剂联合噻托溴铵对比噻托溴铵或单独联合用药治疗慢性阻塞性肺疾病
Cochrane Database Syst Rev. 2016 Jun 6;2016(6):CD008532. doi: 10.1002/14651858.CD008532.pub3.
9
Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation.多中心、随机、安慰剂对照慢性阻塞性肺疾病研究中的行为改变干预：方法学考量与实施
BMJ Open. 2016 Apr 4;6(4):e010109. doi: 10.1136/bmjopen-2015-010109.
10
The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.三联吸入治疗对慢性阻塞性肺疾病患者的疗效和安全性：一项采用贝叶斯方法的系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2015 Nov 3;10:2365-76. doi: 10.2147/COPD.S93191. eCollection 2015.